Author

A. Conery

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Bommi-Reddy· 1 shared A. Hingway· 1 shared D. N. Mayhew· 1 shared E. Terzo· 1 shared J. E. Wilson· 1 shared M. J. Steinbaugh· 1 shared R. J. Sims· 1 shared S. Park-Chouinard· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bommi-Reddy

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

A. Conery, A. Bommi-Reddy, S. Park-Chouinard, D. N. Mayhew, E. Terzo, A. Hingway, M. J. Steinbaugh, J. E. Wilson, R. J. Sims

This study shows that inhibiting CREBBP/EP300 acetyltransferase suppresses ER+ breast cancer growth by disrupting FOXA1-bound enhancers, offering a new therapeutic strategy.

bioRxiv · Dec 26, 2021Cancer Biology